4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-22-036800
Chief Scientific Officer acquired 9,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lachey Jennifer Chief Scientific Officer | 2022-06-14 | Option exercise | +9,400 | $0.30 | $2,820 | 95,100 | D |
| Derivatives | |||||||
| Lachey Jennifer Chief Scientific Officer | 2022-06-14 | Option exercise · Employee Stock Option (right to buy) | −9,400 | 56,705 | D | ||
Loading xslF345X03/doc4.xml…